EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2026

Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in affected individuals. VTE can occur at any age, but it is more common in adults ages 60 years and older and is very rare in children. VTE events are highly dangerous and are associated with high rates of mortality and morbidity.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1142775

Market Research HUB epidemiologists forecast an increase in the diagnosed incident cases of VTE in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), from 896,377 cases in 2016 to 1,071,438 in 2026, at an Annual Growth Rate (AGR) of 1.95%.The number of VTE attacks is forecast to grow from 1,020,991 in 2016 to 1,224,696 in 2026 in the 7MM. Market Research HUB epidemiologists have identified the predominant drivers of this market to be changes in country-specific incidence and procedure rates, as well as in the underlying demographic trends.

Market Research HUB epidemiologists forecast the prevalent cases of VTE in the 7MM from 2016–2026 using nationally-representative, country-specific studies published in peer-reviewed journals that provided the age- and sex-specific incidence of VTE, DVT, and PE in the 7MM. Additionally, they forecast the number of VTE attacks, medically ill discharges at risk of VTE, knee and hip replacements, recurrent VTE cases at one and 10 years, and VTE cases with cancer as comorbidity. Market Research HUB epidemiologists ensured that the forecast methodology was consistent across all the 7MM to allow for a meaningful comparison of the diagnosed incident cases of VTE across these markets.

Make An Enquiry: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1142775

Scope
• The Venous Thromboembolism (VTE) EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of VTE in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiology forecast of diagnosed incident cases of VTE, deep vein thrombosis, and pulmonary embolism segmented by sex and age (in five-year increments beginning at ages zero to four years and ending at 85 years and older) in these seven markets. Additionally, this report includes the number of VTE attacks, medically ill discharges at risk of VTE, primary total knee and hip replacements, recurrent VTE cases after one and 10 years, and diagnosed VTE cases with cancer as comorbidity.
• The VTE epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
• The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
• The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy

The VTE EpiCast series will allow you to:
• Develop business strategies by understanding the trends shaping and driving the global VTE market.
• Quantify patient populations in the global VTE market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for VTE therapeutics in each of the markets covered.
• Identify the percentage of VTE cases with recurrence of VTE and percentage of VTE cases with cancer as comorbidity

Request Free Sample Report: http://www.marketresearchhub.com/report/epicast-report-venous-thromboembolism-epidemiology-forecast-to-2026-report.html

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News At: https://www.industrynewsanalysis.com/

This release was published on openPR.